Costs and health outcomes associated with primary vs secondary care after an asthma-related hospitalization: a population-based study.

Chest

Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, Vancouver, BC, Canada; Centre for Health Evaluation and Outcome Sciences, The University of British Columbia, Vancouver, BC, Canada.

Published: August 2013

Background: Patients with a history of asthma-related hospitalizations are at high risk of readmission and generally consume a large amount of health-care resources. It is not clear if the secondary care provided by specialists after an episode of asthma-related hospitalization is associated with better outcomes compared with the primary care provided by general practitioners.

Methods: Using population-based administrative health data from the province of British Columbia, Canada, we created a propensity-score-matched cohort of individuals who received primary vs secondary care in the 60 days after discharge from asthma-related hospitalization. Total direct asthma-related medical costs (primary outcome) and health service use and measures of medication adherence (secondary outcomes) were compared for the next 12 months.

Results: Two thousand eighty-eight individuals were equally matched between the primary and secondary care groups. There was no difference in the direct asthma-related costs (difference $567; 95% CI, -$276 to $1,410) and rate of readmission (rate ratio [RR] = 1.06; 95% CI, 0.85-1.32) between the secondary and the primary care groups. Patients under secondary care had a higher rate of asthma-related outpatient service use (RR = 1.22; 95% CI, 1.11-1.35) but a lower rate of short-acting β-agonist dispensation (RR = 0.91; 95% CI, 0.85-0.98). The proportion of days covered with a controller medication was higher among the secondary care group (difference of 3.2%; 95% CI, 0.4%-6.0%).

Conclusions: Compared with those who received only primary care, patients who received secondary care showed evidence of more appropriate treatment. Nevertheless, there were no differences in the costs or the risk of readmission. Adherence to asthma medication in both groups was poor, indicating the need for raising the quality of care provided by generalists and specialists alike.

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.12-2773DOI Listing

Publication Analysis

Top Keywords

secondary care
28
primary secondary
12
asthma-related hospitalization
12
care provided
12
primary care
12
care
11
secondary
9
risk readmission
8
outcomes compared
8
received primary
8

Similar Publications

Deep anaesthesia may increase postoperative delirium and consequently subsequent mortality: A secondary analysis of data from the Balanced randomised trial.

Eur J Anaesthesiol

February 2025

From the Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Canada (JY), Department of Anaesthesia and Perioperative Medicine, Auckland City Hospital, Auckland, New Zealand (TGS), Department of Anaesthesia, University of Auckland, Auckland, New Zealand (TGS), Clinic for Anaesthesiology, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, Department of Acute Medicine, University Hospital of Basel, Basel, Switzerland (LAS, SD-K), and Department of Clinical Research, University of Basel, Basel, Switzerland (LAS, SD-K).

View Article and Find Full Text PDF

Background: Achilles tendon rupture is a common orthopedic injury, with an annual incidence of 11-37 per 100000 people, significantly impacting daily life. Minimally invasive surgery, increasingly favored for its reduced risks and comparable fixation strength to open surgery, addresses these challenges. Despite advantages like accelerated recovery, perioperative care poses emotional support, pain management, and rehabilitation challenges, impacting treatment efficacy and patient experience.

View Article and Find Full Text PDF

Background: This study evaluated the efficacy of rituximab (RTX) in primary membranous nephropathy (PMN) patients with incomplete remission and drug dependence after long-term use of calmodulin inhibitors (CNIs). It aims for complete clinical and immunological remission, and cessation of CNI dependence.

Methods: Thirty-six patients were enrolled in the study with two groups: drug-dependent and partial remission or immune non-remission group.

View Article and Find Full Text PDF

Opioids are often part of the post-operative pain regimen after orthopaedic surgery. Novel multimodal post-operative pain control regimens have been developed to decrease the amount of opioid usage due to their negative side effects including nausea, constipation, and addiction. The purpose of this study was to compare the cost of postoperative pain management treatment methods after orthopaedic surgery between opioid/acetaminophen therapy and an opioid-free, multidrug, multimodal pathway.

View Article and Find Full Text PDF

Macrophage Migration Inhibitory Factor and Interleukin 1-β mRNA Levels as Predictors of Antidepressant Treatment Response in Major Depression.

Psychopharmacol Bull

January 2025

Oslin, MD, Veterans Integrated Service Network 4, Mental Illness Research, Education and Clinical Center, Crescenz Veterans Affairs Medical Center and Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

Background: Immunologic measures have been studied as predictors of who will respond to standard antidepressants. Two previous, small studies of pretreatment leukocyte mRNA expression levels of the cytokines macrophage migration inhibitory factor (MIF) and interleukin 1-beta (IL1-β) identified antidepressant treatment responders.

Methods: We tested these findings in 1,299 patients from the PRIME Care study, a multi-center pharmacogenetic depression treatment trial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!